{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:30:23Z","timestamp":1762079423093},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T00:00:00Z","timestamp":1384819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s11606-013-2683-y","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T21:22:34Z","timestamp":1384809754000},"page":"468-476","source":"Crossref","is-referenced-by-count":24,"title":["Physician Underutilization of Effective Medications for Resistant Hypertension at Office Visits in the United States: NAMCS 2006\u20132010"],"prefix":"10.1007","volume":"29","author":[{"given":"Valy","family":"Fontil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Pletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Victor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Bibbins-Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,19]]},"reference":[{"issue":"13","key":"2683_CR1","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.112.097345","volume":"125","author":"E Pimenta","year":"2012","unstructured":"Pimenta E, Calhoun DA. Resistant hypertension: incidence, prevalence, and prognosis. Circulation. 2012;125(13):1594\u20136.","journal-title":"Circulation"},{"issue":"6","key":"2683_CR2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","volume":"57","author":"SD Persell","year":"2011","unstructured":"Persell SD. Prevalence of resistant hypertension in the United States, 2003\u20132008. Hypertension. 2011;57(6):1076\u201380.","journal-title":"Hypertension"},{"key":"2683_CR3","doi-asserted-by":"crossref","unstructured":"Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25):e510\u201326.","DOI":"10.1161\/CIRCULATIONAHA.108.189141"},{"issue":"13","key":"2683_CR4","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","volume":"125","author":"SL Daugherty","year":"2012","unstructured":"Daugherty SL, Powers JD, Magid DJ, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635\u201342.","journal-title":"Circulation"},{"issue":"11 Pt 1","key":"2683_CR5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","volume":"16","author":"MK Nishizaka","year":"2003","unstructured":"Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003;16(11 Pt 1):925\u201330.","journal-title":"Am J Hypertens"},{"issue":"4 Pt 1","key":"2683_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0895-7061(01)02342-1","volume":"15","author":"J Ouzan","year":"2002","unstructured":"Ouzan J, Perault C, Lincoff AM, Carre E, Mertes M. The role of spironolactone in the treatment of patients with refractory hypertension. Am J Hypertens. 2002;15(4 Pt 1):333\u20139.","journal-title":"Am J Hypertens"},{"issue":"6","key":"2683_CR7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","volume":"57","author":"J Vaclavik","year":"2011","unstructured":"Vaclavik J, Sedlak R, Plachy M, et al. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial. Hypertension. 2011;57(6):1069\u201375.","journal-title":"Hypertension"},{"issue":"3","key":"2683_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0895-7061(02)03260-0","volume":"16","author":"HL Vlase","year":"2003","unstructured":"Vlase HL, Panagopoulos G, Michelis MF. Effectiveness of furosemide in uncontrolled hypertension in the elderly: role of renin profiling. Am J Hypertens. 2003;16(3):187\u201393.","journal-title":"Am J Hypertens"},{"issue":"3","key":"2683_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.HYP.0000203147.75714.ba","volume":"47","author":"DA Sica","year":"2006","unstructured":"Sica DA. Chlorthalidone: has it always been the best thiazide-type diuretic? Hypertension. 2006;47(3):321\u20132.","journal-title":"Hypertension"},{"issue":"3","key":"2683_CR10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","volume":"47","author":"ME Ernst","year":"2006","unstructured":"Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47(3):352\u20138.","journal-title":"Hypertension"},{"key":"2683_CR11","unstructured":"National Ambulatory Medical Care Survey. Ambulatory Health Care Data. Available at: http:\/\/www.cdc.gov\/nchs\/ahcd\/about_ahcd.htm . Accessed October 08, 2013."},{"issue":"28","key":"2683_CR12","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH\/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159\u2013219.","journal-title":"Eur Heart J"},{"key":"2683_CR13","unstructured":"NAMCS Survey Instruments. Ambulatory Health Care Data. Available at: http:\/\/www.cdc.gov\/nchs\/ahcd\/ahcd_survey_instruments.htm#namcs . Accessed October 08, 2013."},{"key":"2683_CR14","unstructured":"NAMCS Scope and Sample Design. Ambulatory Health Care Data Available at: http:\/\/www.cdc.gov\/nchs\/ahcd\/ahcd_scope.htm#namcs_scope . Accessed October 08, 2013."},{"key":"2683_CR15","unstructured":"NAMCS Data Collection and Processing. Ambulatory Health Care Data. Available at: http:\/\/www.cdc.gov\/nchs\/ahcd\/ahcd_data_collection.htm#namcs_collection Accessed October 08, 2013."},{"key":"2683_CR16","unstructured":"NAMCS Estimation Procedures. Ambulatory Health Care Data. Available at: http:\/\/www.cdc.gov\/nchs\/ahcd\/ahcd_estimation_procedures.htm#namcs_procedures . Accessed October 08, 2013."},{"key":"2683_CR17","unstructured":"Reliability of Estimates. Ambulatory Health Care Data. Available at: http:\/\/www.cdc.gov\/nchs\/ahcd\/ahcd_estimation_reliability.htm . Accessed October 08, 2013."},{"key":"2683_CR18","unstructured":"National Drug Code Directory. Available at: http:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ucm142438.htm Accessed October 08, 2013."},{"issue":"12","key":"2683_CR19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrcardio.2011.115","volume":"8","author":"G Mancia","year":"2011","unstructured":"Mancia G, Bombelli M, Seravalle G, Grassi G. Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol. 2011;8(12):686\u201393.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"2683_CR20","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.111.180497","volume":"58","author":"MR Hanselin","year":"2011","unstructured":"Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011;58(6):1008\u201313.","journal-title":"Hypertension"},{"issue":"1","key":"2683_CR21","first-page":"41","volume":"160","author":"JJ Caro","year":"1999","unstructured":"Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ. 1999;160(1):41\u20136.","journal-title":"CMAJ"},{"issue":"9","key":"2683_CR22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1524-6175.2007.07194.x","volume":"9","author":"BV Patel","year":"2007","unstructured":"Patel BV, Remigio-Baker RA, Mehta D, Thiebaud P, Frech-Tamas F, Preblick R. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States. J Clin Hypertens (Greenwich). 2007;9(9):692\u2013700.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"19","key":"2683_CR23","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560\u201372.","journal-title":"JAMA"},{"issue":"9","key":"2683_CR24","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","volume":"124","author":"BM Egan","year":"2011","unstructured":"Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011;124(9):1046\u201358.","journal-title":"Circulation"},{"issue":"9","key":"2683_CR25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","volume":"135","author":"LS Phillips","year":"2001","unstructured":"Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825\u201334.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2683_CR26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1753944709356012","volume":"4","author":"J Basile","year":"2010","unstructured":"Basile J, Neutel J. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy. Ther Adv Cardiovasc Dis. 2010;4(2):119\u201327.","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"8","key":"2683_CR27","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1524-6175.2007.07180.x","volume":"9","author":"J Basile","year":"2007","unstructured":"Basile J, Black HR, Flack JM, Izzo JL Jr. The role of therapeutic inertia and the use of fixed-dose combination therapy in the management of hypertension. J Clin Hypertens (Greenwich). 2007;9(8):636\u201345.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"12","key":"2683_CR28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1524-6175.2006.05789.x","volume":"8","author":"WC Cushman","year":"2006","unstructured":"Cushman WC, Basile J. Achieving blood pressure goals: why aren\u2019t we? J Clin Hypertens (Greenwich). 2006;8(12):865\u201372.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"7 Pt 2","key":"2683_CR29","first-page":"481","volume":"10","author":"SE Andrade","year":"2004","unstructured":"Andrade SE, Gurwitz JH, Field TS, et al. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004;10(7 Pt 2):481\u20136.","journal-title":"Am J Manag Care"},{"key":"2683_CR30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1748-5908-2-5","volume":"2","author":"CM Ashton","year":"2007","unstructured":"Ashton CM, Khan MM, Johnson ML, et al. A quasi-experimental test of an intervention to increase the use of thiazide-based treatment regimens for people with hypertension. Implement Sci. 2007;2:5.","journal-title":"Implement Sci"},{"issue":"3","key":"2683_CR31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cjca.2012.03.010","volume":"28","author":"D Clark 3rd","year":"2012","unstructured":"Clark D 3rd, Ahmed MI, Calhoun DA. Resistant hypertension and aldosterone: an update. Can J Cardiol. 2012;28(3):318\u201325.","journal-title":"Can J Cardiol"},{"issue":"9","key":"2683_CR32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1751-7176.2011.00511.x","volume":"13","author":"M Epstein","year":"2011","unstructured":"Epstein M, Calhoun DA. Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics. J Clin Hypertens (Greenwich). 2011;13(9):644\u20138.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"2683_CR33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.HYP.0000103632.19915.0E","volume":"43","author":"BL Carter","year":"2004","unstructured":"Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension. 2004;43(1):4\u20139.","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"2683_CR34","first-page":"S14","volume":"21","author":"J Grimshaw","year":"2006","unstructured":"Grimshaw J, Eccles M, Thomas R, et al. Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966\u20131998. J Gen Intern Med. 2006;21(Suppl 2):S14\u201320.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"2683_CR35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(02)02670-0","volume":"41","author":"RS Stafford","year":"2003","unstructured":"Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 2003;41(1):56\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2683_CR36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11906-000-0007-1","volume":"2","author":"D Siegel","year":"2000","unstructured":"Siegel D. The influence of national guidelines on antihypertensive prescribing patterns. Curr Hypertens Rep. 2000;2(3):247\u201352.","journal-title":"Curr Hypertens Rep"},{"issue":"7","key":"2683_CR37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.2013.108769","volume":"310","author":"MG Jaffe","year":"2013","unstructured":"Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310(7):699\u2013705.","journal-title":"JAMA"},{"key":"2683_CR38","doi-asserted-by":"crossref","first-page":"e7156","DOI":"10.1136\/bmj.e7156","volume":"345","author":"S Stewart","year":"2012","unstructured":"Stewart S, Carrington MJ, Swemmer CH, et al. Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ. 2012;345:e7156.","journal-title":"BMJ"},{"key":"2683_CR39","volume":"3","author":"LG Glynn","year":"2010","unstructured":"Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010;3, CD005182.","journal-title":"Cochrane Database Syst Rev"},{"key":"2683_CR40","unstructured":"Guidelines for the Management of Hypertension. 2005; Available at: http:\/\/www.permanente.net\/healthyheart\/resources\/tools\/KP%20CPG%20Hypertension.pdf . Accessed October 08, 2013."},{"key":"2683_CR41","unstructured":"Hypertension Clinical Practice Guidelines. KAISER PERMANENTE NATIONAL CLINICAL PRACTICE GUIDELINES. 2009; Available at: http:\/\/www.delfini.org\/KP%20BP\/2009_Hypertension_Guidelines_Public.pdf Accessed October 08, 2013."},{"issue":"5 Pt 1","key":"2683_CR42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.amjhyper.2004.11.021","volume":"18","author":"JP Garg","year":"2005","unstructured":"Garg JP, Elliott WJ, Folker A, Izhar M, Black HR, Service RUH. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens. 2005;18(5 Pt 1):619\u201326.","journal-title":"Am J Hypertens"},{"issue":"9","key":"2683_CR43","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1001\/archinte.1991.00400090078014","volume":"151","author":"M Yakovlevitch","year":"1991","unstructured":"Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med. 1991;151(9):1786\u201392.","journal-title":"Arch Intern Med"},{"issue":"5","key":"2683_CR44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2012.33","volume":"9","author":"L Paulis","year":"2012","unstructured":"Paulis L, Steckelings UM, Unger T. Key advances in antihypertensive treatment. Nat Rev Cardiol. 2012;9(5):276\u201385.","journal-title":"Nat Rev Cardiol"},{"key":"2683_CR45","unstructured":"Better technology shows that too many people are treated for high blood pressure. 2013; Available at: http:\/\/articles.washingtonpost.com\/2013-06-03\/national\/39709940_1_have-hypertension-67-million-americans . Accessed October 08, 2013."},{"issue":"5","key":"2683_CR46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrcardio.2011.157","volume":"9","author":"LM Ruilope","year":"2012","unstructured":"Ruilope LM. Current challenges in the clinical management of hypertension. Nat Rev Cardiol. 2012;9(5):267\u201375.","journal-title":"Nat Rev Cardiol"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-013-2683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-013-2683-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-013-2683-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:49:01Z","timestamp":1559396941000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-013-2683-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,19]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["2683"],"URL":"https:\/\/doi.org\/10.1007\/s11606-013-2683-y","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,19]]}}}